Consistent with these reports, our results revealed that PINK1 knockdown in combination with polyphyllin I treatment suppressed mitophagy and promoted DRP1-dependent mitochondrial fission and apoptosis, suggesting that PINK1 might be an important therapeutic target of polyphyllin 1-based breast cancer treatments. This evidence concerns the gene PINK1 and breast carcinoma.